Finance

Lists
300357:SHE
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
CNÂĄ18,87
-0,42%
(-0,080) 1D
16 Okt., 15:04:19 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300357...
Open
CNÂĄ19,15
High
CNÂĄ19,56
Low
CNÂĄ18,69
Mkt. cap
10,22 mjd
Avg. vol.
8,68 m
Volume
5,96 m
Dividend
1,32%
Quarterly dividend
CNÂĄ0,06
Ex-dividend date
09 Jul. 2026
P/E ratio
23,67
52-wk high
CNÂĄ35,84
52-wk low
CNÂĄ18,65
EPS
CNÂĄ0,80
Shares outstanding
523,58 m
No. of employees
2 k
Open
CNÂĄ19,15
High
CNÂĄ19,56
Low
CNÂĄ18,69
Mkt. cap
10,22 mjd
Avg. vol.
8,68 m
Volume
5,96 m
Dividend
1,32%
Quarterly dividend
CNÂĄ0,06
Ex-dividend date
09 Jul. 2026
P/E ratio
23,67
52-wk high
CNÂĄ35,84
52-wk low
CNÂĄ18,65
EPS
CNÂĄ0,80
Shares outstanding
523,58 m
No. of employees
2 k
News stories
From web sources and news partners
About Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
CEO-
Employees1,81 k
Founded19 Sep. 2002
Headquarters-
SectorPharmaceutical industry
Websitewolwobiotech.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
369,12 m
209,04 m
252,84 m
261,32 m
Cost of goods sold
15,75 m
11,11 m
12,02 m
12,18 m
Cost of revenue
15,75 m
11,11 m
12,02 m
12,18 m
Research and development expenses
26,87 m
31,40 m
24,91 m
22,99 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
134,52 m
128,79 m
117,09 m
118,40 m
Operating expense
166,35 m
160,79 m
143,93 m
143,60 m
Total operating expenses
182,11 m
171,90 m
155,95 m
155,79 m
Operating income
187,02 m
37,15 m
96,89 m
105,54 m
Other non operating income
160,14 k
-246,72 k
-24,48 k
-175,66 k
EBT including unusual items
194,75 m
38,43 m
131,78 m
108,66 m
EBT excluding unusual items
194,31 m
41,38 m
131,03 m
109,00 m
Income tax expense
29,94 m
5,57 m
15,27 m
16,59 m
Effective tax rate
15,37%
14,51%
11,59%
15,27%
Other operating expenses
972,53 k
5,99 m
-2,31 m
3,23 m
Net income
167,86 m
36,07 m
119,23 m
94,22 m
Net profit margin
45,47%
17,26%
47,16%
36,05%
Earnings per share
-
-
-
-
Interest and investment income
7,32 m
4,67 m
34,39 m
3,81 m
Interest expense
-190,02 k
-196,48 k
-233,08 k
-172,40 k
Net interest expenses
7,13 m
4,48 m
34,16 m
3,64 m
Depreciation and amortization charges
-
-
-
-
EBITDA
197,88 m
49,60 m
109,35 m
119,27 m
Gain or loss from assets sale
630,07 k
-630,07 k
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme